Medicare plans

Search documents
Factors That Make Centene Stock a Lucrative Pick Right Now
ZACKS· 2025-05-20 18:31
Centene Corporation (CNC) is aided by a growing Medicaid membership, an aging U.S. population, contract wins, strategic acquisitions and a notable financial standing.CNC’s Zacks Rank & Price PerformanceCentene currently carries a Zacks Rank #2 (Buy).The stock has gained 7.3% in the past three months against the industry’s 22.1% decline. The Zacks Medical sector declined 9.9% and the S&P 500 composite decreased 1.3% in the same time frame.Image Source: Zacks Investment ResearchCentene’s Favorable Style Score ...
GoHealth’s Statement on Recent Allegations in the United States False Claims Act Complaint
Globenewswire· 2025-05-07 12:00
GoHealth firmly denies allegations; affirms leadership in regulatory compliance and prioritization of beneficiaries' needs CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, firmly denies the allegations made by the Government in a lawsuit in which the company has been named as a defendant related to events that allegedly occurred between 2016 and 2021. We are disappointed that the Government ...
Humana Gains on Strong Membership Base and Sound Cash Reserves
ZACKS· 2025-03-31 14:15
Core Insights - Humana Inc. (HUM) is well-positioned for growth due to improved premium revenues, an aging U.S. population, acquisitions, and strong cash generation abilities [1] - The company has a strong outlook for 2025, with anticipated revenue growth and earnings per share [3][4] Revenue Growth - Humana's premium revenues increased by 10.7% year over year in 2024, driven by a solid customer base in its Medicaid and Medicare operations [5] - The company expects revenues for 2025 to be between $126 billion and $128 billion, reflecting a 7.8% improvement from 2024 [3] Earnings Performance - Humana has consistently outperformed earnings estimates, with an average surprise of 15.35% over the last four quarters [2] Strategic Acquisitions - The company has pursued strategic acquisitions to enhance its capabilities and expand its footprint, including Family Physicians Group, Curo, Enclara, iCare, and Inclusa [7] - The acquisition of Enclara improved hospice pharmacy services, while the iCare deal expanded its Medicare presence in Wisconsin [7] Financial Position - As of December 31, 2024, Humana held cash and investment securities totaling $20.4 billion, significantly exceeding its long-term debt of $11.1 billion [8] - The company anticipates GAAP cash flow from operations to be between $2.4 billion and $2.9 billion for 2025, supporting its capital deployment strategy [8] Market Demand - The growing elderly population in the U.S. is expected to sustain demand for Humana's Medicare plans, supported by its CenterWell brand introduced in 2022 [6]